Alliance Management - Bridging the Gap Between Drugs and Diagnostics

is being presented by David Kern, RAC MBA, Senior Director, Myraqa and airs on Tuesday, July 12th, 2011. For more details, or to register please visit our site at www.fxconferences.com

Alliance management has long been a core competency in many drug companies, as a way of helping to ensure that compounds discovered by biotech partners make their way to the market. Yet the relationship between drug and diagnostics companies has been a challenge for both sides. Understanding how to manage these strategic relationships is critical to the successful development of a companion diagnostic test, and there can be consequences for a drug company not taking an active role in these alliances.

In this audio conference presentation, our speaker examines the issue, and discusses when and how to start looking for a diagnostics partner, how to structure the relationship, and how best to work together for mutual benefit.

Labeling for Diagnostic Devices: Best Practices

Since Dec. 7, 2003 in-vitro diagnostic (IVD) products must feature the CE mark to be sold in the European Union. With an ever-growing list of languages to be supported, IVD industry faces a dilemma: How can companies provide the required information in multiple languages, while making the information readable on a variety of sizes of labels?

The use of internationally recognized symbols as a substitute for text has been actively promoted to provide users with a uniform method of obtaining product information. Yet many diagnostics companies are struggling with the issues that surround multilingual label design and international symbology.

Labeling for Diagnostic Devices: Best Practices was presented by Andres Heuberger, President, ForeignExchange Translations and is previously recorded. For more details or to download this event, please visit our site at www.fxconferences.com